Biotech finds its next gold rush in autoimmune disease treatments – STAT News Google Alert – Gold
In the first half of 2024, venture capitalists pledged more than $1.7 billion to companies developing treatments for these conditions.
The Heartbeat of World events
In the first half of 2024, venture capitalists pledged more than $1.7 billion to companies developing treatments for these conditions.
